info@intermercatus.com
  • ⁠⁠Home
  • News

About Us

INTERMERCATUS Biotech is a modern technology company operating at the intersection of biotechnology, graphene nanotechnology, digital health, and advanced medical software. Our mission is to develop and implement solutions that genuinely support modern medicine, increase the efficiency of healthcare systems, and relieve doctors and medical staff in their everyday work.

Our Origins and Scientific Foundations

The roots of INTERMERCATUS Biotech date back to 2016, when the first research activities in the field of graphene nanotechnology began, focusing on its broad and practical applications across many areas of everyday life.

From the very beginning, this development extended beyond medicine and veterinary science, encompassing fields related to healthcare, biological safety, functional materials, and advanced technologies that directly impact human well-being.

We focus on the responsible transfer of scientific research into real, scalable, and safe solutions that can be applied in clinical and technological practice.

Our Technology Areas and Innovation Ecosystem

The activities of INTERMERCATUS Biotech cover several complementary technological areas that together form a coherent innovation ecosystem.
Graphene Nanotechnology
One of the key pillars is the development of graphene nanoparticles and graphene-based suspensions, whose antiviral, antibacterial, and antifungal properties have been confirmed through laboratory testing.
The graphene solutions we develop are intended for use in:
  • medicine,
  • veterinary care,
  • protective materials,
  • products requiring elevated biological and hygienic standards.

Our approach to nanotechnology is based on scientific credibility, safety, and preparation for further certification and market implementation.

Innovative Medical Technologies

At the same time, we are conducting work in the field of innovative medical technologies, including solutions for bariatric medicine.
We are currently developing a non-invasive gastric pouch system designed to be introduced laparoscopically, without traditional gastric suturing. The goal of this technology is to:
reduce procedural invasiveness
enhance overall patient safety

shorten post-treatment recovery time

maintain high treatment effectiveness

Digital Health and Artificial Intelligence

A significant area of INTERMERCATUS Biotech’s activity is digital health technologies and artificial intelligence-based systems that support physicians, nurses, and medical personnel.

We develop medical software that enables:

  • recording of patient conversations,
  • automatic transcription,
  • intelligent creation of medical documentation.
Our AI systems analyze clinical data and are capable of summarizing multi-year patient medical histories, supporting diagnostic processes and therapeutic decision-making.
In parallel, we are developing solutions for preliminary disease diagnostic support, aimed at increasing the speed and accuracy of identifying health conditions.

Impact on Healthcare Systems

By operating at the intersection of technology and medicine, INTERMERCATUS Biotech creates solutions that genuinely relieve healthcare systems, reduce administrative burden, and allow doctors to focus on what matters most — treating patients.

Global Presence and Structure

INTERMERCATUS Biotech is headquartered in the United States, while operating internationally through subsidiary companies in:
  • Germany,
  • Poland,
  • the United Kingdom,
  • Albania.
The company is part of the family-and-friends investment fund LEMARRC, which provides stable capital backing, strategic guidance, and long-term development support.
At INTERMERCATUS Biotech, we believe that the future of healthcare is created at the intersection of biotechnology, nanotechnology, artificial intelligence, and clinical experience. We develop technologies that are meaningful, safe, and aligned with the real needs of the modern world.

Contact Us